Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suvidhinath Laboratories is an Indian pharmaceutical company headquartered in Vadodara, Gujarat, specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Founded in 1990, the company has established itself as a key player in the production of anti-diabetic medications, particularly sulfonylureas. Their product portfolio includes widely used treatments such as gliclazide, glibenclamide, and glimepiride. The company operates GMP-compliant manufacturing facilities and serves both domestic and international markets. Suvidhinath Laboratories focuses on high-quality chemical synthesis and process development to support the global generic drug industry. They are recognized for their expertise in second and third-generation sulfonylurea derivatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SUVIDHINATH LABORATORIES.